User:Mr. Ibrahem/Lesinurad
Appearance
![]() | |
![]() | |
Clinical data | |
---|---|
Pronunciation | Zurampic /zəˈræmpɪk/ zə-RAM-pik |
Trade names | Zurampic |
AHFS/Drugs.com | Monograph |
MedlinePlus | a616015 |
License data | |
Routes of administration | By mouth (tablets) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ~100%[1] |
Protein binding | >98% |
Metabolism | Liver (CYP2C9) |
Elimination half-life | ~5 hours |
Excretion | Urine (63%), feces (32%) |
Identifiers | |
| |
Chemical and physical data | |
Formula | C17H14BrN3O2S |
Molar mass | 404.28 g·mol−1 |
3D model (JSmol) | |
| |
|
Lesinurad, sold under the brand name Zurampic, is a medication used to treat high blood uric acid associated with gout.[2] It is only recommended with either allopurinol or febuxostat when these medications are not sufficient.[2] It is taken by mouth.[2]
Common side effects include headache, kidney problems, and GERD.[2] Other side effects may include heart problems and stroke.[2] Safety in pregnancy is unclear.[3] It works by blocking URAT1 and OAT4.[2]
Lesinurad was approved for medical use in the United States in 2015.[2] While it was approved in Europe in 2016, this approval was subsequently withdrawn.[4] It is no longer commercially available in the United States as of 2021.[5]
References[edit]
- ^ "Zurampic (lesinurad) Tablets, for Oral Use. Full Prescribing Information" (PDF). AstraZeneca AB, S-151 85 Sodertalje, Sweden. Archived from the original (PDF) on 24 December 2015. Retrieved 23 December 2015.
- ^ a b c d e f g h i "Lesinurad Monograph for Professionals". Drugs.com. Archived from the original on 21 September 2020. Retrieved 21 November 2021.
- ^ "Lesinurad (Zurampic) Use During Pregnancy". Drugs.com. Archived from the original on 4 December 2020. Retrieved 21 November 2021.
- ^ "Zurampic". Archived from the original on 28 August 2021. Retrieved 21 November 2021.
- ^ "Zurampic Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 1 November 2016. Retrieved 21 November 2021.